Costica Aloman, M.D., joined Westchester Medical Center in January 2024. He is board certified in Internal Medicine, Gastroenterology, and Transplant Hepatology. Dr. Aloman cares for patients with complex and advanced liver diseases, with special focus on patients with end stage liver disease requiring liver transplant as well as post-liver transplant care. He believes in the value of personalized management of liver diseases using the latest up to date approaches and in the importance of practicing wisely and compassionately.

He has extensive experience in managing patients with complex liver cases acquired during his clinical activities at Mount Sinai Medical Center in New York, University of Illinois at Chicago, and Rush University Medical Center in Chicago. He has been listed in Chicago Magazine 2020-2024 on the Top Doctors list. Dr. Aloman is actively involved in basic research of dendritic cell biology, liver fibrosis, mechanisms responsible for autoimmunity, and liver cancer. He has very active in clinical research and has been site principal investigator for clinical trials exploring new treatments for viral hepatitis, alcohol associated liver disease, and liver cirrhosis.

Education

• Fellowship: Mount Sinai Hospital, Transplant Hepatology and Rhode Island Hospital (Providence), Gastroenterology
• Residency: University of Iowa Hospitals and Clincs, Internal Medicine and Fundeni Clinical Hospital, Gastroenterology 
• M.D., University of Illinois College of Medicine 
• Ph.D., Carol Davila University of Medicine and Pharmacy

Areas of Expertise

• Liver transplant evaluation
• End stage liver disease
• Post-liver transplant care
• Autoimmune hepatitis
• Alcohol associated liver disease

Publications

• Dhand A, Okumura K, Nishida S, et. al. "Under the Influence: The Epidemic of Excessive Alcohol Use and Its Impact on Heart and Liver Health." Cardiology in review, (), (2025) . doi: 10.1097/CRD.0000000000000955
• Korenblik R, James S, Smits J, et. al. "Safety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): a multicentre, single-arm clinical trial." The Lancet regional health. Europe, 53(), (2025) 101284. doi: 10.1016/j.lanepe.2025.101284
• Ma N, Yip R, Woodward M, et. al. "Mixture analysis of associations between environmental and workplace toxins and liver damage and telomere length, stratified by race/ethnicity." Journal of environmental sciences (China), 155(), (2025) 316-328. doi: 10.1016/j.jes.2024.08.020
• Daccache J, Eng F, Cao L, et. al. "Single-cell RNA sequencing data identify a conserved population of metallothionein-expressing macrophages that may be ubiquitous in vital human organs." Clinical and translational discovery, 4(5), (2024) . pii: e348. doi: 10.1002/ctd2.348
• Shiffman M, Da B, Goel A, et. al. "Larsucosterol for the Treatment of Alcohol-Associated Hepatitis." NEJM evidence, 4(2), (2025) EVIDoa2400243. doi: 10.1056/EVIDoa2400243
• Belilos E, Strzepka J, Ritz E, et. al. "Characterizing outcomes in a large cohort of latinx patients with autoimmune hepatitis." Annals of hepatology, 30(1), (2024) 101570. doi: 10.1016/j.aohep.2024.101570
• Doyle EH, Aloman C, El-Shamy A, et. al. "Imprinted immune abnormalities in liver transplant patients cured of hepatitis C with antiviral drugs." Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 30(7), (2024) 728-741. doi: 10.1097/LVT.0000000000000342

View All Publications

Memberships and Affiliations

• American Association for the Study of Liver Diseases
• American Gastroenterological Association

Teaching Responsibilities

• Hepatology Teaching Attending-Gastroenterology
• Hepatology Fellowship Program